Agilent presents thought leader award to drs. carl h. june and michael milone

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced professors carl h. june, md, and michael milone, md, ph.d., as recipients of an agilent thought leader award. both scientists are being recognized for their joint contributions to the field of car t-cell mediated cancer immunotherapy, having codeveloped tisagenlecleucel (kymriah™), the first cell and gene therapy product approved by the us fda. the award will focus on defining standards for the design, val
A Ratings Summary
A Quant Ranking